Evidence map›Paper›PMID 24966853›Full record

ReviewFrontiers in microbiology2014

Botulism outbreaks in natural environments - an update.

Mari Espelund, Dag Klaveness

Abstract readReview
In one paragraph

Review in Frontiers in microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Botulism in waterfowl: case report in Argentina.Acta veterinaria Scandinavica · 2025
    Article
  5. Article
  6. Distribution and prevalence ofJournal of medical microbiology · 2025
    Article
  7. Article
  8. Whole genome sequencing of neurotoxin-producingFrontiers in public health · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. The Latent Threat in Wild Birds:Veterinary sciences · 2024
    Review
  13. Article
  14. Complete genomes ofMicrobial genomics · 2024
    Article
  15. Review
  16. Article
  17. ViableEpidemiology and infection · 2023
    Article
  18. Infant Botulism, Israel, 2007-2021.Emerging infectious diseases · 2023
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mari EspelundProtection and Societal Security Division, Norwegian Defence Research Establishment Kjeller, Norway.
Dag KlavenessDepartment of Biological Sciences, University of Oslo Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clostridium botulinum comprises a diverse group of botulinum toxin-producing anaerobic rod-shaped spore-forming bacteria that are ubiquitously distributed in soils and aquatic sediments. Decomposition of plants, algae, and animals creates anaerobic environments that facilitate growth of C. botulinum, which may then enter into food webs leading to intoxication of animals. Via saprophytic utilization of nutrients, the bacteria rapidly sporulate, creating a reservoir of highly robust spores. In the present review, we focus on the occurrence of C. botulinum in non-clinical environments, and examine factors influencing growth and environmental factors associated with botulism outbreaks. We also outline cases involving specific environments and their biota. In wetlands, it has been found that some C. botulinum strains can associate with toxin-unaffected organisms--including algae, plants, and invertebrates--in which the bacteria appear to germinate and stay in the vegetative form for longer periods of time. We suggest the need for future investigations to resolve issues related to the environments in which C. botulinum spores may accumulate and germinate, and where the vegetative forms may multiply.

Indexed as

anaerobebotulismClostridium botulinumlakesserotypesoilsporewetlands

Identifiers

PMID24966853
PMCPMC4052663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.